Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases

Sexually Transmitted Diseases

Volumn 27, Issue 2, 2000, Pages 87-90

  Giuliani, Massimo ^a,b   Rezza, Giovanni ^a   Lepri, Alessandro Cozzi ^a   Di Carlo, Aldo ^a   Maini, Antonio ^a   Crescimbeni, Ercole ^a   Palamara, Guido ^a   Prignano, Grazia ^a   Caprilli, Federico ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; TREPONEMA PALLIDUM; VIRUS TRANSMISSION;

EID: 0033950648     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200002000-00006     Document Type: Article

References (24)

1. Hinuma Y, Komoda H, Chosa T, et al. Antibodies to adult-T-cell-leukemia virus associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer 1982;29:631-635.
2. Blattner WA. Retroviruses. In: Evans AS, ed. Viral infections of humans: epidemiology and control. 3rd ed. New York: Plenum Press, 1989:545-592.
3. Gessain A, Francis H, Sonan T, et al. HTLV-I and tropical spastic paraparesis in Africa. Lancet 1986;i:698.
4. Weiss SH. The evolving epidemiology of human-T-lymphotropic virus type II. J Infect Dis 1994;169:1080-1083.
5. Goubau P, Liu HF, De Lange GG, Vandamme AM, Desmyter J. HTLV-II Seroprevalence in pygmies across Africa since 1970. AIDS Res Human Retroviruses 1993;9:709-713.
6. Lee HH, Swanson P, Rosenblatt JD, et al. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet 1991;337:1435-1439.
7. Murphy EL, Figueroa JP, Gibbs WN, et al. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1989;111:555-560.
8. Murphy EL, Figueroa JP, Gibbs WN, et al. Human-T-lymphotropic-virus type I (HTLV-I) seroprevalence in Jamaica: demographic determinants. Am J Epidemiol 1991;33:1114-1124.
9. Seydel J, Kramer A. Transmission and population dynamics of HTLV-I infection. Int J Cancer 1996;66:197-200.
10. Schwebke J, Calsyn D, Shriver K, et al. Prevalence and epidemiologic correlates of Human T Cell Lymphotropic Virus infection among intravenous drug users. J Infect Dis 1994;169:962-967.
11. Vlahov D, Khabbaz RF, Cohn S, Galai N, Taylor E, Kaplan JE. Incidence and risk factors for human T-Lymphotropic Virus Type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A. J Acquir Immun Defic Syndr Hum Retrovirol 1995; 9:89-96.
12. World Health Organisation (WHO). Acquired immunodeficiency syndrome (AIDS). Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2, and HTLVI/II. Weekly Epidem Rec 1990;65:281-288.
13. van den Hoek JAR, AL EJM, Huisman JG, Goudsmit J, Couthinho RA. Low prevalence of human T-cell leukaemia virus-I and II infection among drug users in Amsterdam, The Netherlands. J Med Virol 1991;34:100-103.
14. Calderon EJ, Gomez-lucia E, Aguado I, Pineda JA, Essex M, Leal M. Absence of HTLV-I and HTLV-II infection in prostitutes in the area of Sevilla, Spain. Eur J Clin Microbiol 1991;10:773-775.
15. Estebanez P, Varela J, Rua-Figueroa M, et al. The presence of HTLV-I/II in non-intravenous drug using in Spanish prostitutes. Int J Sex Transm Dis AIDS 1992;3:62-63.
16. The HTLV European Research Network. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. J Acquir Immun Defic Syndr Hum Retrovirol 1966;13:68-77.
17. Figueroa JP, Morris J, Brathwaite AR, et al. Risk factors for HTLV-I among heterosexual STD clinic attenders. J Acquir Immun Defic Syndr Hum Retrovirol 1995;9:761-768.
18. Figueroa JP, Ward E, Morris J, et al. Incidence of HIV and HTLV-I infection among sexually transmitted disease clinic attenders in Jamaica. J Acquir Immun Defic Syndr Hum Retrovirol 1997;15:232-237.
19. Nakashima K, Kashiwagi S, Kajiyama W, et al. Sexual transmission of human T-lymphotropic virus type I among female prostitutes and among patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan. Am J Epidemiol 1995;141:305-311.
20. Marinucci G, Di Giacomo C, Dato A, et al. Seropositivity for HTLV-I among Italian prisoners. AIDS 1990;4:930-932.
21. Varnier OE, Lillo F, Alexander FF, Forbis RM, Present W, Lazzarin A. HTLV seroreactivity in Italian intravenous drug addicts is primarily due to HTLV-II infection. JAMA 1991;265:597.
22. Lee HH, Galli C, Burczak JD, et al. A multicentric seroepidemiological survey of HTLV-I/II in Italy. Clin Diagn Virol 1994;2: 139-148.
23. Wiktor SZ, Alexander SS, Shaw GM, et al. Distinguishing between HTLV-I and HTLV-II by western blot. Lancet 1990;335:1533.
24. Chen YM, Lee TH, Wiktor SZ, et al. Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection. Lancet 1990;336:1153-1155.